1. Home
  2. WLYB vs NNNN Comparison

WLYB vs NNNN Comparison

Compare WLYB & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Wiley & Sons Inc.

WLYB

John Wiley & Sons Inc.

HOLD

Current Price

$32.15

Market Cap

1.6B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$20.50

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLYB
NNNN
Founded
1807
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Books
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
WLYB
NNNN
Price
$32.15
$20.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.8K
36.8K
Earning Date
03-05-2026
04-28-2026
Dividend Yield
4.46%
N/A
EPS Growth
N/A
N/A
EPS
1.87
0.06
Revenue
$1,665,756,000.00
$6,920,153.00
Revenue This Year
$0.02
N/A
Revenue Next Year
$2.32
N/A
P/E Ratio
$16.08
$366.77
Revenue Growth
N/A
N/A
52 Week Low
$30.10
$5.18
52 Week High
$46.81
$55.65

Technical Indicators

Market Signals
Indicator
WLYB
NNNN
Relative Strength Index (RSI) 46.04 35.65
Support Level $31.97 $28.61
Resistance Level $32.95 $31.52
Average True Range (ATR) 0.53 4.86
MACD 0.26 -1.64
Stochastic Oscillator 45.75 10.20

Price Performance

Historical Comparison
WLYB
NNNN

About WLYB John Wiley & Sons Inc.

John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: